Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

The use of colesevelam hydrochloride in the treatment of dyslipidemia: a review.

Davidson MH.

Expert Opin Pharmacother. 2007 Oct;8(15):2569-78. Review.

PMID:
17931091
2.

Colesevelam hydrochloride.

Steinmetz KL.

Am J Health Syst Pharm. 2002 May 15;59(10):932-9. Review.

PMID:
12040732
3.

Colesevelam: a review of its use in hypercholesterolemia.

Robinson DM, Keating GM.

Am J Cardiovasc Drugs. 2007;7(6):453-65. Review.

PMID:
18076213
4.

Colesevelam hydrochloride: usefulness of a specifically engineered bile acid sequestrant for lowering LDL-cholesterol.

Corsini A, Windler E, Farnier M.

Eur J Cardiovasc Prev Rehabil. 2009 Feb;16(1):1-9. doi: 10.1097/HJR.0b013e32831215db. Review.

PMID:
19237992
5.

Colesevelam hydrochloride: a non-absorbed, polymeric cholesterol-lowering agent.

Davidson MH, Dicklin MR, Maki KC, Kleinpell RM.

Expert Opin Investig Drugs. 2000 Nov;9(11):2663-71. Review.

PMID:
11060828
6.

Colesevelam hydrochloride in the management of dyslipidemia.

Armani A, Toth PP.

Expert Rev Cardiovasc Ther. 2006 May;4(3):283-91. Review.

PMID:
16716090
7.

The role of colesevelam hydrochloride in hypercholesterolemia and type 2 diabetes mellitus.

Brunetti L, Hermes-Desantis ER.

Ann Pharmacother. 2010 Jul-Aug;44(7-8):1196-206. doi: 10.1345/aph.1M728. Review.

PMID:
20551301
8.

Colesevelam hydrochloride in clinical practice: a new approach in the treatment of hypercholesterolaemia.

Florentin M, Liberopoulos EN, Mikhailidis DP, Elisaf MS.

Curr Med Res Opin. 2008 Apr;24(4):995-1009. doi: 10.1185/030079908X280446 . Review.

PMID:
18291066
9.

Colesevelam.

Melian EB, Plosker GL.

Am J Cardiovasc Drugs. 2001;1(2):141-6; discussion 147-8. Review.

PMID:
14728043
10.

Colesevelam: in pediatric patients with heterozygous familial hypercholesterolemia.

Perry CM.

Paediatr Drugs. 2010 Apr 1;12(2):133-40. doi: 10.2165/11204890-000000000-00000. Review.

PMID:
20218749
11.

A review of bile acid sequestrants: potential mechanism(s) for glucose-lowering effects in type 2 diabetes mellitus.

Staels B.

Postgrad Med. 2009 May;121(3 Suppl 1):25-30. doi: 10.3810/pgm.2009.05.suppl53.290. Review.

PMID:
19494475
12.

Review of studies on the effect of bile acid sequestrants in patients with type 2 diabetes mellitus.

Levy P.

Metab Syndr Relat Disord. 2010 Dec;8 Suppl 1:S9-13. doi: 10.1089/met.2010.0087. Review.

PMID:
20946010
13.

Colesevelam hydrochloride: a novel bile acid-binding resin.

Aldridge MA, Ito MK.

Ann Pharmacother. 2001 Jul-Aug;35(7-8):898-907. Review.

PMID:
11485143
14.

Colesevelam: a new bile acid sequestrant.

Wong NN.

Heart Dis. 2001 Jan-Feb;3(1):63-70. Review.

PMID:
11975771
15.

Colesevelam HCl: a non-systemic lipid-altering drug.

Bays H, Dujovne C.

Expert Opin Pharmacother. 2003 May;4(5):779-90. Review.

PMID:
12740000
16.

Colesevelam: potential uses for the newest bile resin.

Steinmetz KL, Schonder KS.

Cardiovasc Drug Rev. 2005 Spring;23(1):15-30. Review.

PMID:
15867945
17.

The role of colesevelam HCl in type 2 diabetes mellitus therapy.

Handelsman Y.

Postgrad Med. 2009 May;121(3 Suppl 1):19-24. doi: 10.3810/pgm.2009.05.suppl53.289. Review.

PMID:
19494474
18.
19.

The efficacy of colesevelam HCl in the treatment of heterozygous familial hypercholesterolemia in pediatric and adult patients.

Davidson M.

Clin Ther. 2013 Aug;35(8):1247-52. doi: 10.1016/j.clinthera.2013.06.014. Review.

PMID:
23916045
20.

Dose-response characteristics of cholesterol-lowering drug therapies: implications for treatment.

Schectman G, Hiatt J.

Ann Intern Med. 1996 Dec 15;125(12):990-1000. Review.

PMID:
8967711

Supplemental Content

Support Center